What is NDC 69238-1250?

69238-1250 is the product NDC for Bexarotene, Bexarotene 75 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bexarotene?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bexarotene NDC 69238-1250 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1250Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1250Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1250-1	69238125001	1 BOTTLE in 1 CARTON (69238-1250-1) / 100 CAPSULE in 1 BOTTLEMarketed from Sep 4, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bexarotene
Generic name (nonproprietary): bexarotene
Active ingredients: Bexarotene — 75 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210105
Marketing start: Sep 4, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 69238-1250_9e70a6ae-538e-406a-9814-a0a21121ba3dSPL ID 9e70a6ae-538e-406a-9814-a0a21121ba3dSPL set ID d7fc7c7b-2ecf-4543-8bb4-9b4415d66613RxCUI 308725UNII A61RXM4375UPC 0369238125016
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238125001 followed by a unit qualifier and the quantity

Package 69238-1250-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 30, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. Bexarotene capsules are a retinoid indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-1250

What is NDC 69238-1250?: 69238-1250 is the product NDC for Bexarotene, Bexarotene 75 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bexarotene.
What is the active ingredient?: Bexarotene.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bexarotene?: 7 other product NDCs are listed under this name. See all Bexarotene NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bexarotene NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	Camber Pharmaceuticals, Inc.	31722-380	31722-0380-01
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	AvKARE	42291-072	42291-0072-01
Bexarotene	Bexarotene 10 mg/g	GelTopical	Amneal Pharmaceuticals NY LLC	69238-2088	69238-2088-06
bexarotene	Bexarotene 75 mg/1	Capsule, Liquid filledOral	Actavis Pharma, Inc.	0591-2832	00591-2832-01
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	Upsher-Smith Laboratories, Inc.	0832-0285	00832-0285-00
Bexarotene	Bexarotene 75 mg/1	Capsule, Liquid filledOral	ANI Pharmaceuticals, Inc.	43975-315	43975-0315-10
Bexarotene	Bexarotene 75 mg/1	Capsule, Liquid filledOral	Mylan Pharmaceuticals Inc.	0378-6955	00378-6955-01

Other NDCs under ANDA 210105

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210105
Product	Strength	Form · route	Labeler	Product NDC
Bexarotene	Bexarotene 75 mg/1	CapsuleOral	AvKARE	42291-072